Opioids

Featured

  • David Luckey, senior international and defense researcher, and Jayme Fuglesten, director of Congressional Relations at RAND, on Capitol Hill, photo by Grace Evans/RAND Corporation

    Q&A

    A New Approach to Fighting Synthetic Opioids: Q&A with David Luckey and Jayme Fuglesten

    Apr 26, 2022

    The opioid crisis isn't just about drug policy or law. It involves national security, homeland security, intelligence, diplomacy, supply chain issues, and cryptocurrency. Drawing on RAND's expertise across all those areas, the Commission on Combating Synthetic Opioid Trafficking delivered a plan, a call to action about what it's going to take to save lives.

  • Boxes of naloxone spray and fentanyl test strips in a container at The Legionnaire bar in Oakland, California, March 3, 2022, photo by Nathan Frandino/Reuters

    Commentary

    A Greater Focus On Harm Reduction Will Save Lives

    Apr 29, 2022

    For decades, elected officials brushed off harm reduction as a viable option for reducing the harms of drug use over concerns of enabling drug consumption. But now, these strategies are front and center, spoken aloud, from the largest podium in the land, and during prime time. What caused this historic about-face?

Explore Opioids

Research conducted by